AUTH/2692/1/14 & AUTH/2693/1/14: Anonymous consultant physician v Lundbeck and Takeda (Brintellix) – out of scope/no breach | PMCPA Case

📊

Key facts

⌄

Case number	AUTH/2692/1/14 and AUTH/2693/1/14
Parties	Anonymous consultant physician v Lundbeck and Takeda
Product	Brintellix
Issue	Promotion of Brintellix
Complaint received	06 January 2014
Completed	04 March 2014
Outcome	No breach; outwith the scope of the Code
Clauses cited	Not stated
Sanctions	Not stated
Case report	No case report (outwith scope)

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI

🎬 Expert Video Walkthrough

🎬

Video walkthrough — coming for members

Subscribe now and get expert video analysis for every case as we publish them.

Subscribe — from £299/yr

📋

⌄

An anonymous consultant physician complained about the promotion of Brintellix.
The complaint was made against Lundbeck and Takeda.
The PMCPA concluded the matter was outwith the scope of the Code and did not publish a case report.

⚖️

⌄

🔒

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value

£249/year

Annual — save £99

£29/mo

Monthly

Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →